APOE and Alzheimer disease: Zhang & Shen (2012) suggested an approach that incorporated the Apoe genotype into the multimodal model, including MRI, FDG PET, and CSF; it achieved an accuracy of 93.3% to distinguish AD from NL and 83.2% to distinguish MCI from NL.